Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS: EMMA · Delayed Price · USD
0.0713
-0.0317 (-30.78%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Emmaus Life Sciences Employees
As of December 31, 2023, Emmaus Life Sciences had 55 total employees, including 51 full-time and 4 part-time employees. The number of employees did not change compared to the previous year.
Employees
55
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$538,127
Profits / Employee
-$67,873
Market Cap
4.55M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
EMMA News
- 9 days ago - Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program - PRNewsWire
- 19 days ago - Emmaus Life Sciences Reports 2023 Financial Results - PRNewsWire
- 3 months ago - Emmaus Life Sciences Reports Delayed Filing of Annual Report - PRNewsWire
- 6 months ago - Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico - PRNewsWire
- 8 months ago - Emmaus Life Sciences Reports Q3 2023 Financial Results - PRNewsWire
- 11 months ago - Emmaus Life Sciences Reports Management Changes - PRNewsWire
- 1 year ago - Emmaus Life Sciences Reports Q2 2023 Financial Results - PRNewsWire
- 1 year ago - Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman - PRNewsWire